US equities |
NVDA $175.92 ▼-5.74% AMD $505.84 ▲+12.65% MU $727.69 ▲+5.46% SPCX $141.03 ▲+5.03% SNDK $881.47 ▲+5.56% AMZN $267.98 ▲+3.35% TSLA $377.51 ▲+5.39% AAPL $351.35 ▲+2.62%
FinancialContent

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

10.95 +0.50 (+4.74%)
Delayed Quote Updated: 2:28 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DBV Technologies S.A. - American Depositary Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBVT Stock Earnings: DBV Technologies Beats EPS, Beats Revenue for Q4 2023 ↗
DBVT stock results show that DBV Technologies beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
A Preview Of DBV Technologies's Earnings ↗
 
Via Benzinga
News headline image
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 7, 2024 ↗
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
News headline image
DBV Technologies And 2 Other Stocks Under $2 Insiders Are Buying ↗
The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Top 5 Health Care Stocks That Could Blast Off In December ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Present New Data at ACAAI 2023
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming Investor Conference
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying ↗
The Dow Jones closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
DBV Technologies And 3 Other Penny Stocks Insiders Are Buying ↗
The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
News headline image
Cambium Networks, SolarEdge Technologies, trivago And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract. 
Via Benzinga
News headline image
DBV Technologies Advances Peanut Allergy Program With FDA Support On Pediatric Studies ↗
DBV Technologies (NASDAQ: DBVT) received Type C meeting written responses from the FDA on key study design elements for the COMFORT Toddlers and COMFORT Children supplemental safety studies in 1 –... 
Via Benzinga
News headline image
DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
From DBV Technologies S.A.
Via GlobeNewswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >